Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile-Reference-Cited by-同舟云学术

Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile

Published:2020-09-04 Issue:19 Volume:63 Page:10946-10971
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Sniecikowska Joanna¹^ORCID,Gluch-Lutwin Monika¹,Bucki Adam¹^ORCID,Więckowska Anna¹^ORCID,Siwek Agata¹,Jastrzebska-Wiesek Magdalena¹,Partyka Anna¹,Wilczyńska Daria¹,Pytka Karolina¹,Latacz Gniewomir¹,Przejczowska-Pomierny Katarzyna¹,Wyska Elżbieta¹,Wesołowska Anna¹,Pawłowski Maciej¹,Newman-Tancredi Adrian²^ORCID,Kolaczkowski Marcin¹^ORCID

Affiliation:

1. Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Kraków, Poland

2. Neurolixis, Castres, France

Funder

Narodowe Centrum Nauki

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00814

Reference68 articles.